APA (7th ed.) Citation

Y, N., S, I., K, T., N, S., H, A., K, S., . . . S, A. (2025). Significance of Body Surface Area Correction for Cisplatin Eligibility Based on Renal Function of Patients With Muscle-Invasive Bladder Cancer. Clinical genitourinary cancer, 23(3), 102339. https://doi.org/10.1016/j.clgc.2025.102339

Chicago Style (17th ed.) Citation

Y, Naito, et al. "Significance of Body Surface Area Correction for Cisplatin Eligibility Based on Renal Function of Patients With Muscle-Invasive Bladder Cancer." Clinical Genitourinary Cancer 23, no. 3 (2025): 102339. https://doi.org/10.1016/j.clgc.2025.102339.

MLA (9th ed.) Citation

Y, Naito, et al. "Significance of Body Surface Area Correction for Cisplatin Eligibility Based on Renal Function of Patients With Muscle-Invasive Bladder Cancer." Clinical Genitourinary Cancer, vol. 23, no. 3, 2025, p. 102339, https://doi.org/10.1016/j.clgc.2025.102339.